Valneva SE ( VALN) - Key Metrics
VALN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.37 | -$0.33 | -$0.19 | -$0.20 |
| 2026Q1 | $0.36 | -$0.37 | $0 | -$0.01 |
| 2025Q4 | $0.55 | -$0.58 | -$0.54 | -$0.56 |
| 2025Q3 | $0.34 | -$0.52 | -$0.20 | -$0.21 |
| 2025Q2 | $0.63 | -$0.15 | -$0.04 | -$0.05 |
VALN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.37 |
| 2026Q1 | 0% | -3.56 |
| 2025Q4 | 0% | -3.24 |
| 2025Q3 | 0% | -5.00 |
| 2025Q2 | 0% | -7.99 |
VALN
Price: $5.61
52 week price:
Earnings Per Share: -2.02 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: France
Volume: 8187
Market Capitalization: 555.7 million